Engine Biosciences Company

Engine Biosciences Pte. Ltd. develops a validated platform for drug discovering, developing combination therapeutics, and cellular reprogramming. The company's artificial intelligence and genetic perturbation platform allows researchers and drug developers to uncover the gene interactions and biological networks. It provides test therapies that specifically target genetic interactions, and make analyses and predictions for precision medicine applications. The platform provides drug discovery, such as target discovery, drug repositioning, repurposing, pathway, and massive online analysis (MoA) analysis.
Technology: Preclinical Experiment Execution
Industry: Biomarker Development
Headquarters: San Francisco, California, United States
Founded Date: 2014
Employees Number: 1-10
Funding Status: Seed

Visit Website
contact@enginebio.com
Register and Claim Ownership